SCHEMBL5050427

SCHEMBL5050427

c1ccc(C(NC2CN(CC3CCOCC3)CC[N]2)c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 1/20 0.40
CHRM4 P08173 3/20 0.39
CHRM2 P08172 2/20 0.39
HTR4 Q13639 9/20 0.36
CYP2D6 P10635 3/20 0.36
CYP3A4 P08684 3/20 0.36
ACHE P22303 1/20 0.34
CACNA2D1 P54289 2/20 0.34
CACNA1B Q00975 2/20 0.34
CACNB1 Q02641 2/20 0.34
CCR1 P32246 1/20 0.34
CACNA1C Q13936 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5053752 0.77 GRM5 (0.38) TACR2CHRM4CHRM2HTR4CYP2D6
SCHEMBL5053738 0.77 TACR2 (0.38) TACR2CHRM4CHRM2HTR4CYP2D6
SCHEMBL5133014 0.76 TACR2 (0.37) TACR2CHRM4CHRM2HTR4CYP2D6
SCHEMBL4271731 0.69 TACR2 (0.56) TACR2CACNA2D1CACNA1BCACNB1CCR1
SCHEMBL375228 0.66 GAA (0.46) CYP3A4
SCHEMBL8231635 0.63 SIGMAR1 (0.58) TACR2ACHE
SCHEMBL4279734 0.63 TACR2 (0.60) TACR2CYP2D6CYP3A4ACHECACNA2D1
SCHEMBL15757380 0.62 HTR2B (0.51) TACR2ACHE
SCHEMBL4273009 0.62 TACR2 (0.56) TACR2CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL28572642 0.61 KDM1A (0.41) CYP2D6ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976841-A1 HETEROCYCLIC AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Neuromed Pharmaceuticals, Ltd. (CA) 2008-10-08 EP claimed
WO-2007071035-A1 HETEROCYCLIC AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD. (CA) 2007-06-28 WO claimed